Peptide-based composition against papillomavirus infection
US5989548A · kind A · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 18, 1997 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Dec 18, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising an antigenic amount of peptides derived from the L1 and L2 OFR's of human papillomavirus type 16 coupled to a carrier or in multimer form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.